For the year ending 2025-12-31, ABBV has $133,960M in assets. $5,229M in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Cash and equivalents | 5,229 | 5,524 | 12,814 | 9,201 |
| Short-term investments | 28 | 31 | 2 | 28 |
| Accounts receivable, net | 12,589 | 10,919 | 11,155 | 11,254 |
| Inventories | 4,951 | 4,181 | 4,099 | 3,579 |
| Prepaid expenses and other | 6,265 | 4,927 | 4,932 | 4,401 |
| Total current assets | 29,062 | 25,582 | 33,002 | 28,463 |
| Investments | 268 | 279 | 304 | 241 |
| Property and equipment, net | 5,628 | 5,134 | 4,989 | 4,935 |
| Net carrying amount | 47,360 | - | 55,307 | 66,527 |
| Indefinite-lived intangible assets | 5,281 | - | 303 | 912 |
| Intangible assets, net | 52,641 | 60,068 | 55,610 | 67,439 |
| Goodwill | 35,640 | 34,956 | 32,293 | 32,156 |
| Other assets | 10,721 | 9,142 | 8,513 | 5,571 |
| Total assets | 133,960 | 135,161 | 134,711 | 138,805 |
| Short-term borrowings | 2,499 | - | 0 | 1 |
| Current portion of long-term debt and finance lease obligations | 6,056 | 6,804 | 7,191 | 4,135 |
| Accounts payable and accrued liabilities | 34,734 | 31,945 | 30,650 | 25,402 |
| Total current liabilities | 43,289 | 38,749 | 37,841 | 29,538 |
| Long-term debt and finance lease obligations | 58,941 | 60,340 | 52,194 | 59,135 |
| Deferred income taxes | 2,389 | 2,579 | 1,952 | 2,190 |
| Contingent consideration liabilities | 21,919 | 19,077 | 17,938 | 14,915 |
| Liabilities for unrecognized tax benefits | 5,573 | 5,049 | 6,681 | 6,502 |
| Pension and other post-employment benefits | 1,410 | 1,234 | 1,538 | 1,638 |
| Income taxes payable | 364 | 1,261 | 2,182 | 2,985 |
| Other | 3,303 | 3,508 | 3,988 | 4,615 |
| Other long-term liabilities | 32,569 | 30,129 | 32,327 | 30,655 |
| Common stock, 0.01 par value, 4,000,000,000 shares authorized, 1,838,678,628 shares issued as of december31, 2025 and 1,831,594,494 as of december31, 2024 | 18 | 18 | 18 | 18 |
| Common stock held in treasury, at cost, 70,802,593 shares as of december31, 2025 and 66,337,508 as of december31, 2024 | 9,146 | 8,201 | 6,533 | 4,594 |
| Additional paid-in capital | 22,495 | 21,333 | 20,180 | 19,245 |
| Accumulated deficit | -15,493 | -7,900 | -1,000 | 4,784 |
| Accumulated other comprehensive loss | -1,144 | -1,925 | -2,305 | -2,199 |
| Total stockholders' equity (deficit) | -3,270 | 3,325 | 10,360 | 17,254 |
| Noncontrolling interest | 42 | 39 | 37 | 33 |
| Total equity (deficit) | -3,228 | 3,364 | 10,397 | 17,287 |
| Total liabilities and equity | 133,960 | 135,161 | 134,711 | 138,805 |
AbbVie Inc. (ABBV)
AbbVie Inc. (ABBV)